Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00323778 · ClinicalTrials.gov registry record · Phase 3
Prospective Assessment of the Efficacy of Hyaluronate Knee Injections in Patients With Osteoarthritis
A Phase 3 study, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- Phase 3
- Development phase
- 40
- Enrollment target
NCT00323778 is a Phase 3 study that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 40 participants.
The verdict
NCT00323778, a Phase 3 study, was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study looks at the effect of an injectable medication called Hyalgan on the cartilage of the knee in people who have osteoarthritis ("wear and tear arthritis") of the knee. Hyalgan is a medication which is injected into the knee, and is FDA approved to treat knee arthritis. We will be using magnetic resonance imaging (MRI) and x-rays to look at knee cartilage to see how it responds over the course of a year to the injections. A comparison to patients taking oral pain medication will be made.
Interventions
- DRUG Hyalgan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00323778
The ClinicalTrials.gov registry entry for NCT00323778 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyalgan is the first listed.
NCT00323778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00323778 about?
NCT00323778 is a clinical study titled "Prospective Assessment of the Efficacy of Hyaluronate Knee Injections in Patients With Osteoarthritis". This study looks at the effect of an injectable medication called Hyalgan on the cartilage of the knee in people who have osteoarthritis ("wear and tear arthritis") of the knee. Hyalgan is a medication which is injected into the knee, and is FDA approved to treat knee arthritis. We will be using mag...
What is the current status of trial NCT00323778?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 40 participants. The study started on 2006-05.
What interventions are being tested in trial NCT00323778?
The interventions under investigation include: Hyalgan (DRUG).
Who is sponsoring clinical trial NCT00323778?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.